Today: 10 June 2026
ConocoPhillips stock climbs on Venezuela oil shake-up; $10 billion claims back in focus
6 January 2026
2 mins read

ConocoPhillips stock climbs on Venezuela oil shake-up; $10 billion claims back in focus

New York, Jan 5, 2026, 20:48 EST — Market closed

  • COP closed up about 2.6% as energy stocks rallied on Venezuela headlines.
  • J.P. Morgan analysts said ConocoPhillips’ outstanding Venezuela claims approach $10 billion.
  • Traders are watching U.S. talks with oil executives later this week, plus API and EIA inventory data.

ConocoPhillips (COP) shares closed up about 2.6% on Monday at $99.20. Energy stocks rallied after President Donald Trump said Washington would keep an embargo on Venezuelan oil exports in place for now while his administration lined up talks later this week with oil executives on reviving output there — a project analysts say would take years and billions of dollars.

Investors are also revisiting the company’s Venezuela-related claims, rather than its near-term drilling prospects. J.P. Morgan analysts said ConocoPhillips has outstanding claims approaching $10 billion, and the stock rose more than 2% alongside Exxon Mobil, while Chevron ended 5% higher. “This type of crude aligns well with the configuration of U.S. Gulf Coast refineries,” said Ahmad Assiri, a research strategist at Pepperstone. Reuters

Arbitration awards are legal judgments from international tribunals; collecting them often depends on negotiating a settlement or attaching assets. That makes policy signals — sanctions, contracts, and enforcement — as important as barrels in the ground for the near-term COP trade.

Crude prices ended higher after a volatile session. Brent settled up $1.01 at $61.76 a barrel and U.S. West Texas Intermediate gained $1 to $58.32 as traders weighed possible shifts in Venezuelan flows; OPEC+ — OPEC and allies including Russia — kept output policy unchanged.

U.S. inventory data is the next near-term macro test for oil prices. Analysts in a Reuters poll expect crude stockpiles rose by about 1.3 million barrels last week, ahead of American Petroleum Institute figures due Tuesday and the Energy Information Administration report on Wednesday.

ConocoPhillips traded between $97.11 and $102.98 on Monday, leaving the $100 level as the first psychological marker for traders into Tuesday. The company is scheduled to discuss fourth-quarter results on Feb. 5 at 12:00 p.m. Eastern.

With oil in the high-$50s to low-$60s, investors will be listening for how management frames spending discipline and cash returns, and whether it sees room to protect payouts if prices stay soft. Any incremental detail on Venezuela — timelines, legal avenues, or a settlement path — would add another variable to that outlook.

But the Venezuela trade is headline-driven and hard to model. A prolonged embargo, legal uncertainty and the scale of investment required to rebuild fields could leave little near-term upside beyond sentiment, especially in a market already wrestling with ample supply.

ConocoPhillips is one of the world’s largest independent oil and gas producers, and its share price often tracks shifts in crude expectations. That linkage makes Wednesday’s government inventory data and any fresh moves in Brent and WTI key inputs for positioning.

Investors will watch for readouts from the administration’s planned meetings later this week and for any shift in Venezuela-related policy language. For ConocoPhillips, the next company-specific checkpoint is its Feb. 5 earnings call.

Stock Market Today

  • Parabilis Medicines Raises $670 Million in Record-Breaking Biotech IPO
    June 10, 2026, 5:42 AM EDT. Parabilis Medicines raised a record $670 million in its initial public offering (IPO), making it the largest biotech listing to date. The cancer-focused company sold 33.5 million shares at $20 each, with a potential to increase proceeds by $100 million via underwriters' option. Parabilis aims to advance its lead candidate zolucatetide, targeting desmoid tumors, familial adenomatous polyposis, and other cancers, supported by FDA fast-track designation. The company also plans to invest $190 million in developing other drug candidates. Led by CEO Mathai Mammen, Parabilis leverages a novel helicon peptide platform to target previously undruggable proteins. The firm has secured substantial funding rounds since 2021 and recently partnered with Regeneron in a deal including $50 million upfront and $75 million equity investment.

Latest articles

DraftKings (DKNG) Moves After Prediction-Market News — Traders Focus on Stock

DraftKings (DKNG) Moves After Prediction-Market News — Traders Focus on Stock

10 June 2026
DraftKings shares soared 11.34% to $27.59 after revealing a 24% month-over-month jump in annualized consumer volume to $1.3 billion and a 34% rise in total volume traded to $3.1 billion in its Predictions product for May, based on preliminary, unaudited data, outpacing a falling Nasdaq and spotlighting investor focus on the product’s revenue potential and DraftKings’ strategic push.
Micron Stock’s $1 Trillion AI Test Is Here as Traders Look to June 24

Micron Stock’s $1 Trillion AI Test Is Here as Traders Look to June 24

10 June 2026
Micron shares fell 1.5% to $935.89 as the AI-chip rally cooled, despite bullish analyst calls and price targets up to $1,625; investors await the June 24 earnings report to see if tight memory chip supply and AI demand can sustain the stock’s trillion-dollar valuation amid broader market jitters and shifting sentiment.
Ondas Stock Comes Back Into the Spotlight After 13% Drop; Drone Trade Faces Fresh Challenge

Ondas Dips Premarket After 2.7 Million-Share Filing

10 June 2026
SoFi Technologies traded near $16.47 in early premarket, little changed as investors weighed its AI and digital asset product push against a risk-off market mood, with no fresh earnings news and inflation data looming that could impact rates, loan demand, and fintech valuations.
Ondas Dips Premarket After 2.7 Million-Share Filing

SoFi Stock Holds Ahead of Pre-Market Test as Wall Street Grows Defensive

10 June 2026
Rolls-Royce shares rebounded 1.5% in London after Tuesday’s 2.68% drop, as investors weighed fresh airline criticism over engine delays against the company’s reaffirmed 2026 profit and cash flow guidance; CEO Tufan Erginbilgic said Rolls had a “strong start to the year,” but risks remain if airline pressure leads to higher costs or slower cash conversion.
LVMH Drops Following Quick Rally, RBC Still Sees Recovery for Luxury

LVMH Drops Following Quick Rally, RBC Still Sees Recovery for Luxury

10 June 2026
LVMH shares slipped 0.49% to €489.90 in Paris after a four-day rebound, as investors weighed RBC’s reiterated Buy rating with a €600 target against ongoing 2026 losses and a 24% year-to-date drop; all eyes now turn to July’s first-half results for signs of recovery in Fashion & Leather Goods and any relief from Middle East weakness.
Why MercadoLibre (MELI) stock jumped nearly 9% on Venezuela shock headlines
Previous Story

Why MercadoLibre (MELI) stock jumped nearly 9% on Venezuela shock headlines

Marks & Spencer (MKS.L) shares fall as Jan 8 Christmas trading update looms
Next Story

Marks & Spencer (MKS.L) shares fall as Jan 8 Christmas trading update looms

Go toTop